Athletic Cardiac Adaptation in Males Is a Consequence of Elevated Myocyte Mass

Circulation: Cardiovascular Imaging

Volumn 9, Issue 4, 2016, Pages

  McDiarmid, Adam K ^a   Swoboda, Peter P ^a   Erhayiem, Bara ^a   Lancaster, Rosalind E ^b,c   Lyall, Gemma K ^a,b,c   Broadbent, David A ^a   Dobson, Laura E ^a   Musa, Tarique A ^a   Ripley, David P ^a   Garg, Pankaj ^a   Greenwood, John P ^a   Ferguson, Carrie ^b,c   Plein, Sven ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b Centre for Neuroregeneration School of Biomedical Sciences   (United Kingdom)

^c UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

Athlete's heart; cardiovascular magnetic resonance imaging; ECV; exercise physiology; hypertrophy remodeling; T1 mapping

Indexed keywords

GADOBUTROL; CONTRAST MEDIUM;

ADAPTATION; ADULT; AEROBIC CAPACITY; ANAEROBIC THRESHOLD; ARTICLE; ATHLETE; BICYCLE ERGOMETER; CARDIAC ADAPTATION; CARDIOPULMONARY EXERCISE TEST; CARDIOVASCULAR FUNCTION; CARDIOVASCULAR MAGNETIC RESONANCE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; CYCLING; EXTRACELLULAR SPACE; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HUMAN; INTRACELLULAR SPACE; LUNG GAS EXCHANGE; MALE; MUSCLE CELL; NUCLEAR MAGNETIC RESONANCE SCANNER; PRIORITY JOURNAL; RUNNING; TRAINING; TRIATHLON; CARDIOMYOPATHIES; CASE CONTROL STUDY; EXERCISE TEST; HYPERTROPHY, LEFT VENTRICULAR; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; OXYGEN CONSUMPTION; PHYSIOLOGY; PROSPECTIVE STUDY;

ADAPTATION, PHYSIOLOGICAL; ADULT; ATHLETES; CARDIOMYOPATHIES; CASE-CONTROL STUDIES; CONTRAST MEDIA; EXERCISE TEST; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; OXYGEN CONSUMPTION; PROSPECTIVE STUDIES;

EID: 84969219484     PISSN: 19419651     EISSN: 19420080     Source Type: Journal    
DOI: 10.1161/CIRCIMAGING.115.003579     Document Type: Article

References (41)

1. Harmon KG, Drezner JA, Wilson MG, Sharma S. Incidence of sudden cardiac death in athletes: a state-of-the-art review. Br J Sports Med. 2014;48:1185-1192. doi: 10.1136/bjsports-2014-093872.
2. Bellenger NG, Davies LC, Francis JM, Coats AJ, Pennell DJ. Reduction in sample size for studies of remodeling in heart failure by the use of cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2000;2:271-278.
3. Myerson SG, Bellenger NG, Pennell DJ. Assessment of left ventricular mass by cardiovascular magnetic resonance. Hypertension. 2002;39:750-755.
4. Sado DM, Flett AS, Banypersad SM, White SK, Maestrini V, Quarta G, Lachmann RH, Murphy E, Mehta A, Hughes DA, McKenna WJ, Taylor AM, Hausenloy DJ, Hawkins PN, Elliott PM, Moon JC. Cardiovascular magnetic resonance measurement of myocardial extracellular volume in health and disease. Heart. 2012;98:1436-1441. doi: 10.1136/heartjnl-2012-302346.
5. Sado DM, White SK, Piechnik SK, Banypersad SM, Treibel T, Captur G, Fontana M, Maestrini V, Flett AS, Robson MD, Lachmann RH, Murphy E, Mehta A, Hughes D, Neubauer S, Elliott PM, Moon JC. Identification and assessment of Anderson-Fabry disease by cardiovascular magnetic resonance noncontrast myocardial T1 mapping. Circ Cardiovasc Imaging. 2013;6:392-398. doi: 10.1161/CIRCIMAGING.112.000070.
6. Neilan TG, Coelho-Filho OR, Shah RV, Abbasi SA, Heydari B, Watanabe E, Chen Y, Mandry D, Pierre-Mongeon F, Blankstein R, Kwong RY, Jerosch-Herold M. Myocardial extracellular volume fraction from T1 measurements in healthy volunteers and mice: relationship to aging and cardiac dimensions. JACC Cardiovasc Imaging. 2013;6:672-683. doi: 10.1016/j.jcmg.2012.09.020.
7. McDiarmid AK, Swoboda PP, Erhayiem B, Ripley DP, Kidambi A, Broadbent DA, Higgins DM, Greenwood JP, Plein S. Single bolus versus split dose gadolinium administration in extra-cellular volume calculation at 3 Tesla. J Cardiovasc Magn Reson. 2015;17:6. doi: 10.1186/s12968-015-0112-6.
8. Messroghli DR, Bainbridge GJ, Alfakih K, Jones TR, Plein S, Ridgway JP, Sivananthan MU. Assessment of regional left ventricular function: accuracy and reproducibility of positioning standard short-axis sections in cardiac MR imaging. Radiology. 2005;235:229-236. doi: 10.1148/radiol.2351040249.
9. Alfakih K, Plein S, Thiele H, Jones T, Ridgway JP, Sivananthan MU. Normal human left and right ventricular dimensions for MRI as assessed by turbo gradient echo and steady-state free precession imaging sequences. J Magn Reson Imaging. 2003;17:323-329. doi: 10.1002/jmri.10262.
10. Alfakih K, Plein S, Bloomer T, Jones T, Ridgway J, Sivananthan M. Comparison of right ventricular volume measurements between axial and short axis orientation using steady-state free precession magnetic resonance imaging. J Magn Reson Imaging. 2003;18:25-32. doi: 10.1002/jmri.10329.
11. Rogers T, Dabir D, Mahmoud I, Voigt T, Schaeffter T, Nagel E, Puntmann VO. Standardization of T1 measurements with MOLLI in differentiation between health and disease-the ConSept study. J Cardiovasc Magn Reson. 2013;15:78. doi: 10.1186/1532-429X-15-78.
12. Rossiter HB, Kowalchuk JM, Whipp BJ. A test to establish maximum O2 uptake despite no plateau in the O2 uptake response to ramp incremental exercise. J Appl Physiol (1985). 2006;100:764-770. doi: 10.1152/japplphysiol.00932.2005.
13. Buchfuhrer MJ, Hansen JE, Robinson TE, Sue DY, Wasserman K, Whipp BJ. Optimizing the exercise protocol for cardiopulmonary assessment. J Appl Physiol Respir Environ Exerc Physiol. 1983;55:1558-1564.
14. Lamarra N, Whipp BJ, Ward SA, Wasserman K. Effect of interbreath fluctuations on characterizing exercise gas exchange kinetics. J Appl Physiol (1985). 1987;62:2003-2012.
15. Beaver WL, Wasserman K, Whipp BJ. A new method for detecting anaerobic threshold by gas exchange. J Appl Physiol (1985). 1986;60:2020-2027.
16. Whipp BJ, Ward SA, Wasserman K. Respiratory markers of the anaerobic threshold. Adv Cardiol. 1986;35:47-64.
17. Bowen TS, Cannon DT, Begg G, Baliga V, Witte KK, Rossiter HB. A novel cardiopulmonary exercise test protocol and criterion to determine maximal oxygen uptake in chronic heart failure. J Appl Physiol (1985). 2012;113:451-458. doi: 10.1152/japplphysiol.01416.2011.
18. Arbab-Zadeh A, Perhonen M, Howden E, Peshock RM, Zhang R, Adams-Huet B, Haykowsky MJ, Levine BD. Cardiac remodeling in response to 1 year of intensive endurance training. Circulation. 2014;130:2152-2161. doi: 10.1161/CIRCULATIONAHA.114.010775.
19. Scharhag J, Schneider G, Urhausen A, Rochette V, Kramann B, Kindermann W. Athlete's heart: right and left ventricular mass and function in male endurance athletes and untrained individuals determined by magnetic resonance imaging. J Am Coll Cardiol. 2002;40:1856-1863.
20. Steding K, Engblom H, Buhre T, Carlsson M, Mosén H, Wohlfart B, Arheden H. Relation between cardiac dimensions and peak oxygen uptake. J Cardiovasc Magn Reson. 2010;12:8. doi: 10.1186/1532-429X-12-8.
21. Milliken MC, Stray-Gundersen J, Peshock RM, Katz J, Mitchell JH. Left ventricular mass as determined by magnetic resonance imaging in male endurance athletes. Am J Cardiol. 1988;62:301-305.
22. Flett AS, Hayward MP, Ashworth MT, Hansen MS, Taylor AM, Elliott PM, McGregor C, Moon JC. Equilibrium contrast cardiovascular magnetic resonance for the measurement of diffuse myocardial fibrosis: preliminary validation in humans. Circulation. 2010;122:138-144. doi: 10.1161/CIRCULATIONAHA.109.930636.
23. White SK, Sado DM, Fontana M, Banypersad SM, Maestrini V, Flett AS, Piechnik SK, Robson MD, Hausenloy DJ, Sheikh AM, Hawkins PN, Moon JC. T1 mapping for myocardial extracellular volume measurement by CMR: bolus only versus primed infusion technique. JACC Cardiovasc Imaging. 2013;6:955-962. doi: 10.1016/j.jcmg.2013.01.011.
24. Lockie T, Nagel E, Redwood S, Plein S. Use of cardiovascular magnetic resonance imaging in acute coronary syndromes. Circulation. 2009;119:1671-1681. doi: 10.1161/CIRCULATIONAHA.108.816512.
25. Dabir D, Child N, Kalra A, Rogers T, Gebker R, Jabbour A, Plein S, Yu CY, Otton J, Kidambi A, McDiarmid A, Broadbent D, Higgins DM, Schnackenburg B, Foote L, Cummins C, Nagel E, Puntmann VO. Reference values for healthy human myocardium using a T1 mapping methodology: results from the International T1 Multicenter cardiovascular magnetic resonance study. J Cardiovasc Magn Reson. 2014;16:69. doi: 10.1186/s12968-014-0069-x.
26. Kehr E, Sono M, Chugh SS, Jerosch-Herold M. Gadolinium-enhanced magnetic resonance imaging for detection and quantification of fibrosis in human myocardium in vitro. Int J Cardiovasc Imaging. 2008;24:61-68. doi: 10.1007/s10554-007-9223-y.
27. Treibel TA, White SK, Moon JC. Myocardial tissue characterization: histological and pathophysiological correlation. Curr Cardiovasc Imaging Rep. 2014;7:9254. doi: 10.1007/s12410-013-9254-9.
28. Lorell BH, Carabello BA. Left ventricular hypertrophy: pathogenesis, detection, and prognosis. Circulation. 2000;102:470-479.
29. Puntmann VO, Voigt T, Chen Z, Mayr M, Karim R, Rhode K, Pastor A, Carr-White G, Razavi R, Schaeffter T, Nagel E. Native T1 mapping in differentiation of normal myocardium from diffuse disease in hypertrophic and dilated cardiomyopathy. JACC Cardiovasc Imaging. 2013;6:475-484. doi: 10.1016/j.jcmg.2012.08.019.
30. Varnava AM, Elliott PM, Baboonian C, Davison F, Davies MJ, McKenna WJ. Hypertrophic cardiomyopathy: histopathological features of sudden death in cardiac troponin T disease. Circulation. 2001;104:1380-1384.
31. Maron MS. Contrast-enhanced CMR in HCM: what lies behind the bright light of LGE and why it now matters. JACC Cardiovasc Imaging. 2013;6:597-599. doi: 10.1016/j.jcmg.2012.10.028.
32. McCrohon JA, Moon JC, Prasad SK, McKenna WJ, Lorenz CH, Coats AJ, Pennell DJ. Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance. Circulation. 2003;108:54-59. doi: 10.1161/01. CIR.0000078641.19365.4C.
33. Ho CY, Abbasi SA, Neilan TG, Shah RV, Chen Y, Heydari B, Cirino AL, Lakdawala NK, Orav EJ, González A, López B, Diéz J, Jerosch-Herold M, Kwong RY. T1 measurements identify extracellular volume expansion in hypertrophic cardiomyopathy sarcomere mutation carriers with and without left ventricular hypertrophy. Circ Cardiovasc Imaging. 2013;6:415-422. doi: 10.1161/CIRCIMAGING.112.000333.
34. aus dem Siepen F, Buss SJ, Messroghli D, Andre F, Lossnitzer D, Seitz S, Keller M, Schnabel PA, Giannitsis E, Korosoglou G, Katus HA, Steen H. T1 mapping in dilated cardiomyopathy with cardiac magnetic resonance: quantification of diffuse myocardial fibrosis and comparison with endomyocardial biopsy. Eur Heart J Cardiovasc Imaging. 2015;16:210-216. doi: 10.1093/ehjci/jeu183.
35. Wakatsuki T, Schlessinger J, Elson EL. The biochemical response of the heart to hypertension and exercise. Trends Biochem Sci. 2004;29:609-617. doi: 10.1016/j.tibs.2004.09.002.
36. Hart G. Exercise-induced cardiac hypertrophy: a substrate for sudden death in athletes? Exp Physiol. 2003;88:639-644.
37. Coelho-Filho OR, Shah RV, Mitchell R, Neilan TG, Moreno H Jr, Simonson B, Kwong R, Rosenzweig A, Das S, Jerosch-Herold M. Quantification of cardiomyocyte hypertrophy by cardiac magnetic resonance: implications for early cardiac remodeling. Circulation. 2013;128:1225-1233. doi: 10.1161/CIRCULATIONAHA.112.000438.
38. La Gerche A, Burns AT, Mooney DJ, Inder WJ, Taylor AJ, Bogaert J, Macisaac AI, Heidbüchel H, Prior DL. Exercise-induced right ventricular dysfunction and structural remodelling in endurance athletes. Eur Heart J. 2012;33:998-1006. doi: 10.1093/eurheartj/ehr397.
39. Wilson M, O'Hanlon R, Prasad S, Deighan A, Macmillan P, Oxborough D, Godfrey R, Smith G, Maceira A, Sharma S, George K, Whyte G. Diverse patterns of myocardial fibrosis in lifelong, veteran endurance athletes. J Appl Physiol (1985). 2011;110:1622-1626. doi: 10.1152/japplphysiol.01280.2010.
40. Utomi V, Oxborough D, Ashley E, Lord R, Fletcher S, Stembridge M, Shave R, Hoffman MD, Whyte G, Somauroo J, Sharma S, George K. Predominance of normal left ventricular geometry in the male 'athlete's heart'. Heart. 2014;100:1264-1271. doi: 10.1136/heartjnl-2014-305904.
41. Harmon KG, Asif IM, Klossner D, Drezner JA. Incidence of sudden cardiac death in National Collegiate Athletic Association athletes. Circulation. 2011;123:1594-1600. doi: 10.1161/CIRCULATIONAHA.110.004622